TFA
UTHR icon

Transamerica Financial Advisors’s United Therapeutics UTHR Stock Holding History

Transamerica Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
345
+35
+11% +$19.7K 0.02% 438
2026
Q1 		$184K Buy
310
+141
+83% +$70.2K 0.02% 408
2025
Q4 		$82.3K Buy
169
+62
+58% +$28.9K 0.01% 482
2025
Q3 		$44.9K Buy
+107
New +$36K ﹤0.01% 497
2024
Q3 		– Sell
-1
Closed -$1K – 661
2024
Q2 		$1K Hold
1
– – ﹤0.01% 534
2024
Q1 		$1K Hold
1
– – ﹤0.01% 580
2023
Q4 		$1K Hold
1
– – ﹤0.01% 596
2023
Q3 		$1K Hold
1
– – ﹤0.01% 615
2023
Q2 		$1K Hold
1
– – ﹤0.01% 585
2023
Q1 		$1K Hold
1
– – ﹤0.01% 570
2022
Q4 		$1K Hold
1
– – ﹤0.01% 655
2022
Q3 		$1K Hold
1
– – ﹤0.01% 615
2022
Q2 		$1K Buy
+1
New +$203 ﹤0.01% 626
2013
Q3 		– Sell
-5,862
Closed -$386K – 634
2013
Q2 		$386K Buy
+5,862
New +$378K 0.06% 133

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Transamerica Financial Advisors's UTHR Position: Q2 2026 in Review

Transamerica Financial Advisors increased its United Therapeutics (UTHR) stake by 11% in Q2 2026, buying an estimated $19.7K and bringing the position to 345 shares worth $187K. The position accounts for 0.02% of the portfolio, ranked #438.

Transamerica Financial Advisors first reported a position in UTHR in Q2 2013 and has held it in 14 quarters since. The position peaked at $386K in Q2 2013. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Transamerica Financial Advisors held 345 shares of United Therapeutics worth $187K as of Q2 2026.
  • Transamerica Financial Advisors bought 35 United Therapeutics shares in Q2 2026, an estimated $19.7K.
  • United Therapeutics made up 0.02% of Transamerica Financial Advisors's portfolio in Q2 2026, its #438 holding.
  • Transamerica Financial Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 14 quarters since.
  • Transamerica Financial Advisors's United Therapeutics position peaked at $386K in Q2 2013.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.